NCT05154123 - Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 16, 2021

Primary Completion Date

December 23, 2021

Study Completion Date

December 23, 2021

Conditions

Healthy Volunteer Study

Interventions

DRUG

Drug: AT-527 + rosuvastatin

"* Day 1: A single dose of rosuvastatin will be administered.~* Day 8: A single dose of AT-527 and rosuvastatin will be co-administered."

DRUG

AT-527 + rosuvastatin

"* Day 1: A single dose of rosuvastatin will be administered.~* Day 8: A single staggered dose of AT-527 and rosuvastatin will be administered (2 hours later)"

Trial Locations (1)

Unknown

Atea Study Site, Québec